Instead, use compliant phrasing emphasizing improved skin resilience or recovery support
Injectable or compounded GHK-Copper for clinical use is a different matter and is not FDA-approved as a finished drug product
Clinical studies have documented modest reductions in fasting glucose, HbA1c, and LDL cholesterol with oral supplementation, though effect sizes are generally smaller and evidence quality more variable than for conventional pharmaceutical agents like metformin
It has also been picked up by the MAHA movement
However, this is not the typical response, and most patients have no ill effects from this supplement.
(All committee members underwent the same ethics review and vetting process required of all FDA advisory committee members, Emily Hilliard, a spokesperson for the Department of Health and Human Services, told me in an email.) The decision is only a recommendation, and the FDA would still need to sign off on an actual rule change